Geneos Wealth Management’s Armata Pharmaceuticals ARMP Stock Holding History

Geneos Wealth Management’s Portfolio ARMP Stock Details ARMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$596	Hold	92	–	–	﹤0.01%	2460
2026 Q1	$942	Hold	92	–	–	﹤0.01%	2414
2025 Q4	$578	Buy	+92	New	+$504	﹤0.01%	2451
2020 Q4	–	Sell	-449	Closed	-$1K	–	2889
2020 Q3	$1K	Hold	449	–	–	﹤0.01%	2485
2020 Q2	$1K	Hold	449	–	–	﹤0.01%	2419
2020 Q1	$1K	Hold	449	–	–	﹤0.01%	2334
2019 Q4	$1K	Hold	449	–	–	﹤0.01%	2431
2019 Q3	$1K	Sell	449 -71	-14%	-$279	﹤0.01%	2361
2019 Q2	$2K	Buy	+520	New	+$1.99K	﹤0.01%	2291

Other funds holding ARMP

MAM

Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DIG

Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Geneos Wealth Management's ARMP Position: Q2 2026 in Review

Geneos Wealth Management held its Armata Pharmaceuticals (ARMP) position steady in Q2 2026 at 92 shares worth $596. The position accounts for ﹤0.01% of the portfolio, ranked #2460.

Geneos Wealth Management first reported a position in ARMP in Q2 2019 and has held it in 9 quarters since. The position peaked at $2K in Q2 2019. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

Geneos Wealth Management held 92 shares of Armata Pharmaceuticals worth $596 as of Q2 2026.
Geneos Wealth Management left its Armata Pharmaceuticals share count unchanged in Q2 2026.
Armata Pharmaceuticals made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #2460 holding.
Geneos Wealth Management first reported a position in Armata Pharmaceuticals in Q2 2019 and has held it in 9 quarters since.
Geneos Wealth Management's Armata Pharmaceuticals position peaked at $2K in Q2 2019.
53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.